Info

Intermediate/high

55%

49%

43%

4 or 5

High

44%

40%

26%

A predictive model for aggressive non

-Hodgkin':

; lymphoma. The International Non-

Hodgkin's

Lymphoma Prognostic Factors Project. (1993) N Engl J Med, 329, 987-994.

Treatment of indolent lymphomas

FL and SLL comprise the majority of patients and are treated in a similar way. These diseases are usually responsive to chemotherapy and radio therapy but unless truly localised, inevitably recur. There is no firm evidence of a curative therapy for advanced disease. Many patients have few or no symptoms; the decision to initiate treatment and choice of treatment must take account of individual quality of life issues. At each stage, the pros and cons of treatment options should be shared with the patient to reach an agreed treatment decision.

0 0

Post a comment